RDHL · RedHill Biopharma Ltd.
Market Cap
$4.41M
Shares
6.08M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$286K
-96.4%
FY2025
Net Income
-$429K
+94.8%
FY2025
Gross Margin
60.31%
+13.3pp
FY2024
Operating Margin
-2776.92%
-2696.4pp
FY2025
Diluted EPS
$0.00
FY2025
Operating Cash Flow
-$9.65M
-3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $286K | $8.04M | $6.53M | $61.8M | $85.76M | $64.36M | $6.29M | $8.36M | $4.01M | $101K | $3000 | |
| — | $3.19M | $3.46M | $33.34M | $49.41M | $36.89M | $2.26M | $2.84M | $2.13M | — | — | |
| — | $4.85M | $3.07M | $28.46M | $36.35M | $27.47M | $4.03M | $5.52M | $1.88M | $101K | $3000 | |
| — | 60.31% | 47.03% | 46.06% | 42.39% | 42.68% | 64.09% | 66.06% | 46.94% | 100% | 100% | |
| $2.02M | $1.59M | $3.53M | $7.28M | $29.5M | $16.49M | $17.42M | $24.86M | $32.97M | $25.24M | $17.77M | |
| — | $5.95M | $14.76M | $35.44M | $55.62M | $49.29M | $18.33M | $12.49M | $12.01M | $1.56M | $1.39M | |
| $384K | $588K | $1.45M | $2.14M | $1.91M | $1.71M | $997K | $90K | $81K | $44K | $36K | |
| -$7.94M | -$6.48M | -$9.55M | -$42.84M | -$81.14M | -$63.68M | -$43.2M | -$39.33M | -$51.97M | -$30.54M | -$22M | |
| -2776.92% | -80.5% | -146.22% | -69.33% | -94.61% | -98.95% | -686.71% | -470.47% | -1297.03% | -30240.59% | -733400% | |
| -$7.56M | -$5.89M | -$8.1M | -$40.71M | -$79.22M | -$61.97M | -$42.2M | -$39.24M | -$51.89M | -$30.5M | -$21.97M | |
| $1.46M | $1.51M | $9.25M | $42.39M | $16.66M | $12.76M | $438K | $167K | $77K | $375K | $212K | |
| -$429K | -$8.27M | $23.92M | -$71.67M | -$97.74M | -$76.17M | -$42.3M | -$38.82M | -$45.54M | -$29.37M | -$21.09M | |
| -150% | -102.8% | 366.25% | -115.97% | -113.98% | -118.36% | -672.45% | -464.35% | -1136.61% | -29079.21% | -703000% | |
| USD/shares | $0.00 | $0.00 | $0.01 | -$0.12 | -$5.25 | -$5.25 | -$140.00 | -$170.00 | -$260.00 | -$230.00 | -$190.00 |
| USD/shares | $0.00 | $0.00 | $0.01 | -$0.12 | -$5.25 | -$5.25 | -$140.00 | -$170.00 | -$260.00 | -$240.00 | -$190.00 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.